Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer-Reference-Cited by-同舟云学术

Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer

Published:1994-11 Issue:5 Part 2 Volume:152 Page:1743-1748
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Pearson Jay D.¹,Carter H. Ballentine¹

Affiliation:

1. From the Longitudinal Studies Branch, Gerontology Research Center, National Institute on Aging, and Department of Urology, Johns Hopkins University School of Medicine, James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference31 articles.

1. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling;Meyer;J. Urol.,1982

2. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression;Carroll;J. Urol.,1993

3. Patterns of progression in prostate cancer;McNeal;Lancet,1986

4. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate;McNeal;Cancer,1990

5. Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence?;Whittemore;J. Natl. Cancer Inst.,1991

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TEP/TDM 18F-choline dans les récidives biologiques des cancers de la prostate traites par radiothérapie externe ou curiethérapie : impact du PSA et de sa cinétique;Médecine Nucléaire;2020-01

2. Prostate Cancer Patients’ Refusal of Cancer-Directed Surgery: A Statewide Analysis;Prostate Cancer;2015

3. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer;Urologic Oncology: Seminars and Original Investigations;2013-08

4. Active surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypes;Asian Journal of Andrology;2012-04-16

5. Sixteen-Year Longitudinal Changes in Serum Prostate-Specific Antigen Levels: The Olmsted County Study;Mayo Clinic Proceedings;2012-01